Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin.

Andrews SF, Chambers MJ, Schramm CA, Plyler J, Raab JE, Kanekiyo M, Gillespie RA, Ransier A, Darko S, Hu J, Chen X, Yassine HM, Boyington JC, Crank MC, Chen GL, Coates E, Mascola JR, Douek DC, Graham BS, Ledgerwood JE, McDermott AB.

Immunity. 2019 Aug 20;51(2):398-410.e5. doi: 10.1016/j.immuni.2019.06.024. Epub 2019 Jul 23.

PMID:
31350180
2.

Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.

Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS.

Nat Immunol. 2019 Jun;20(6):765. doi: 10.1038/s41590-019-0395-0.

PMID:
30980067
3.

Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells.

Bu W, Joyce MG, Nguyen H, Banh DV, Aguilar F, Tariq Z, Yap ML, Tsujimura Y, Gillespie RA, Tsybovsky Y, Andrews SF, Narpala SR, McDermott AB, Rossmann MG, Yasutomi Y, Nabel GJ, Kanekiyo M, Cohen JI.

Immunity. 2019 May 21;50(5):1305-1316.e6. doi: 10.1016/j.immuni.2019.03.010. Epub 2019 Apr 9.

PMID:
30979688
4.

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages.

Corbett KS, Moin SM, Yassine HM, Cagigi A, Kanekiyo M, Boyoglu-Barnum S, Myers SI, Tsybovsky Y, Wheatley AK, Schramm CA, Gillespie RA, Shi W, Wang L, Zhang Y, Andrews SF, Joyce MG, Crank MC, Douek DC, McDermott AB, Mascola JR, Graham BS, Boyington JC.

MBio. 2019 Feb 26;10(1). pii: e02810-18. doi: 10.1128/mBio.02810-18.

5.

Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals.

Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, Holden-Wiltse J, Topham DJ, Treanor JJ, Ertl HC, Schmader KE, Cobey S, Krammer F, Hensley SE, Greenberg H, He XS, Wilson PC.

Cell Host Microbe. 2019 Mar 13;25(3):357-366.e6. doi: 10.1016/j.chom.2019.01.002. Epub 2019 Feb 19.

PMID:
30795982
6.

Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.

Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS.

Nat Immunol. 2019 Mar;20(3):362-372. doi: 10.1038/s41590-018-0305-x. Epub 2019 Feb 11. Erratum in: Nat Immunol. 2019 Apr 12;:.

7.

Elastic modulus and toughness of orb spider glycoprotein glue.

Opell BD, Clouse ME, Andrews SF.

PLoS One. 2018 May 30;13(5):e0196972. doi: 10.1371/journal.pone.0196972. eCollection 2018.

8.

Shaping a universally broad antibody response to influenza amidst a variable immunoglobulin landscape.

Andrews SF, McDermott AB.

Curr Opin Immunol. 2018 Aug;53:96-101. doi: 10.1016/j.coi.2018.04.009. Epub 2018 May 4. Review.

PMID:
29730560
9.

Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.

Jegaskanda S, Mason RD, Andrews SF, Wheatley AK, Zhang R, Reynoso GV, Ambrozak DR, Santos CP, Luke CJ, Matsuoka Y, Brenchley JM, Hickman HD, Talaat KR, Permar SR, Liao HX, Yewdell JW, Koup RA, Roederer M, McDermott AB, Subbarao K.

J Virol. 2018 Apr 13;92(9). pii: e01970-17. doi: 10.1128/JVI.01970-17. Print 2018 May 1.

10.

Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.

Andrews SF, Joyce MG, Chambers MJ, Gillespie RA, Kanekiyo M, Leung K, Yang ES, Tsybovsky Y, Wheatley AK, Crank MC, Boyington JC, Prabhakaran MS, Narpala SR, Chen X, Bailer RT, Chen G, Coates E, Kwong PD, Koup RA, Mascola JR, Graham BS, Ledgerwood JE, McDermott AB.

Sci Immunol. 2017 Jul 14;2(13). pii: eaan2676. doi: 10.1126/sciimmunol.aan2676.

PMID:
28783708
11.

Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation.

Lau D, Lan LY, Andrews SF, Henry C, Rojas KT, Neu KE, Huang M, Huang Y, DeKosky B, Palm AE, Ippolito GC, Georgiou G, Wilson PC.

Sci Immunol. 2017 Jan 27;2(7). pii: eaai8153. doi: 10.1126/sciimmunol.aai8153.

12.

Is It Possible to Develop a "Universal" Influenza Virus Vaccine? Immunogenetic Considerations Underlying B-Cell Biology in the Development of a Pan-Subtype Influenza A Vaccine Targeting the Hemagglutinin Stem.

Andrews SF, Graham BS, Mascola JR, McDermott AB.

Cold Spring Harb Perspect Biol. 2018 Jul 2;10(7). pii: a029413. doi: 10.1101/cshperspect.a029413. Review.

PMID:
28663207
13.

Immune history profoundly affects broadly protective B cell responses to influenza.

Andrews SF, Huang Y, Kaur K, Popova LI, Ho IY, Pauli NT, Henry Dunand CJ, Taylor WM, Lim S, Huang M, Qu X, Lee JH, Salgado-Ferrer M, Krammer F, Palese P, Wrammert J, Ahmed R, Wilson PC.

Sci Transl Med. 2015 Dec 2;7(316):316ra192. doi: 10.1126/scitranslmed.aad0522.

14.

High preexisting serological antibody levels correlate with diversification of the influenza vaccine response.

Andrews SF, Kaur K, Pauli NT, Huang M, Huang Y, Wilson PC.

J Virol. 2015 Mar;89(6):3308-17. doi: 10.1128/JVI.02871-14. Epub 2015 Jan 14.

15.

Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.

Pauli NT, Kim HK, Falugi F, Huang M, Dulac J, Henry Dunand C, Zheng NY, Kaur K, Andrews SF, Huang Y, DeDent A, Frank KM, Charnot-Katsikas A, Schneewind O, Wilson PC.

J Exp Med. 2014 Nov 17;211(12):2331-9. doi: 10.1084/jem.20141404. Epub 2014 Oct 27.

16.

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Linderman SL, Chambers BS, Zost SJ, Parkhouse K, Li Y, Herrmann C, Ellebedy AH, Carter DM, Andrews SF, Zheng NY, Huang M, Huang Y, Strauss D, Shaz BH, Hodinka RL, Reyes-Terán G, Ross TM, Wilson PC, Ahmed R, Bloom JD, Hensley SE.

Proc Natl Acad Sci U S A. 2014 Nov 4;111(44):15798-803. doi: 10.1073/pnas.1409171111. Epub 2014 Oct 20.

17.

Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans.

Ellebedy AH, Krammer F, Li GM, Miller MS, Chiu C, Wrammert J, Chang CY, Davis CW, McCausland M, Elbein R, Edupuganti S, Spearman P, Andrews SF, Wilson PC, García-Sastre A, Mulligan MJ, Mehta AK, Palese P, Ahmed R.

Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8. doi: 10.1073/pnas.1414070111. Epub 2014 Aug 25.

18.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.

J Virol. 2014 Apr;88(8):3976-85. doi: 10.1128/JVI.03095-13. Epub 2014 Jan 22.

19.

High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire.

DeKosky BJ, Ippolito GC, Deschner RP, Lavinder JJ, Wine Y, Rawlings BM, Varadarajan N, Giesecke C, Dörner T, Andrews SF, Wilson PC, Hunicke-Smith SP, Willson CG, Ellington AD, Georgiou G.

Nat Biotechnol. 2013 Feb;31(2):166-9. doi: 10.1038/nbt.2492. Epub 2013 Jan 20.

20.

Global analysis of B cell selection using an immunoglobulin light chain-mediated model of autoreactivity.

Andrews SF, Zhang Q, Lim S, Li L, Lee JH, Zheng NY, Huang M, Taylor WM, Farris AD, Ni D, Meng W, Luning Prak ET, Wilson PC.

J Exp Med. 2013 Jan 14;210(1):125-42. doi: 10.1084/jem.20120525. Epub 2012 Dec 24.

21.

Tools to therapeutically harness the human antibody response.

Wilson PC, Andrews SF.

Nat Rev Immunol. 2012 Oct;12(10):709-19. doi: 10.1038/nri3285. Review.

PMID:
23007571
22.

Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Li GM, Chiu C, Wrammert J, McCausland M, Andrews SF, Zheng NY, Lee JH, Huang M, Qu X, Edupuganti S, Mulligan M, Das SR, Yewdell JW, Mehta AK, Wilson PC, Ahmed R.

Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9047-52. doi: 10.1073/pnas.1118979109. Epub 2012 May 21.

23.
24.

Developmentally regulated expression of MEF2C limits the response to BCR engagement in transitional B cells.

Andrews SF, Dai X, Ryu BY, Gulick T, Ramachandran B, Rawlings DJ.

Eur J Immunol. 2012 May;42(5):1327-36. doi: 10.1002/eji.201142226.

25.

The anergic B cell.

Andrews SF, Wilson PC.

Blood. 2010 Jun 17;115(24):4976-8. doi: 10.1182/blood-2010-03-276352. No abstract available.

26.

Myeloid translocation gene 16b is a dual A-kinase anchoring protein that interacts selectively with plexins in a phospho-regulated manner.

Fiedler SE, Schillace RV, Daniels CJ, Andrews SF, Carr DW.

FEBS Lett. 2010 Mar 5;584(5):873-7. doi: 10.1016/j.febslet.2010.02.007. Epub 2010 Feb 9.

27.

Serine 649 phosphorylation within the protein kinase C-regulated domain down-regulates CARMA1 activity in lymphocytes.

Moreno-García ME, Sommer K, Haftmann C, Sontheimer C, Andrews SF, Rawlings DJ.

J Immunol. 2009 Dec 1;183(11):7362-70. doi: 10.4049/jimmunol.0902438. Epub 2009 Nov 16.

28.

Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Meyer-Bahlburg A, Bandaranayake AD, Andrews SF, Rawlings DJ.

J Immunol. 2009 Apr 1;182(7):4065-75. doi: 10.4049/jimmunol.0802961.

29.

Transitional B cells exhibit a B cell receptor-specific nuclear defect in gene transcription.

Andrews SF, Rawlings DJ.

J Immunol. 2009 Mar 1;182(5):2868-78. doi: 10.4049/jimmunol.0802368.

30.

Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation.

Meyer-Bahlburg A, Andrews SF, Yu KO, Porcelli SA, Rawlings DJ.

J Exp Med. 2008 Jan 21;205(1):155-68. doi: 10.1084/jem.20071088. Epub 2008 Jan 7.

31.

Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?

Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon AL, Uzzo RG, Pollack A.

Cancer. 2005 Jul 15;104(2):299-304. Review.

32.

The role of protein kinase A anchoring via the RII alpha regulatory subunit in the murine immune system.

Schillace RV, Andrews SF, Galligan SG, Burton KA, Starks HJ, Bouwer HG, McKnight GS, Davey MP, Carr DW.

J Immunol. 2005 Jun 1;174(11):6847-53.

33.

Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.

Andrews SF, Anderson PR, Eisenberg BL, Hanlon AL, Pollack A.

Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):475-80.

PMID:
15145165
34.

Identification and characterization of myeloid translocation gene 16b as a novel a kinase anchoring protein in T lymphocytes.

Schillace RV, Andrews SF, Liberty GA, Davey MP, Carr DW.

J Immunol. 2002 Feb 15;168(4):1590-9.

35.

Comparing a computer-based childhood vaccination registry with parental vaccination cards: a population-based study of Delaware children.

Ortega AN, Andrews SF, Katz SH, Dowshen SA, Curtice WS, Cannon ME, Stewart DC, Kaiser K.

Clin Pediatr (Phila). 1997 Apr;36(4):217-21.

PMID:
9114993
36.

Adolescent suicide.

Low BP, Andrews SF.

Med Clin North Am. 1990 Sep;74(5):1251-64. Review.

PMID:
2201855

Supplemental Content

Loading ...
Support Center